INFORMING THE PATIENT ABOUT OF IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN KAZAKHSTAN

Abstract

Introduction: The implantable cardioverter defibrillator (ICD) has been implemented in most countries for the
treatment of patients at high risk of sudden death from arrhythmia, and has been proven to be effective. To provide high
quality care it was identified that system have to patient-oriented. Thus the satisfaction of ICD patients with information
about cardioverter-defibrillator implantation one of the crucial issue.
The aim is to study the satisfaction of ICD patients with information about technology cardioverter-defibrillator
implantation.
Materials and methods: The online survey was conducted by phone. The oral consent to participate in the survey
was obtained. The survey provided in Russian or Kazakh languages, depending patient preferences. The survey was
conducted in the period 2020, among patients who received an ICD in the period from 2017 to 2020 in Almaty city and
Kyzylorda region. Statistical processing was carried out using the SPSS 13 software. The Local Ethics Committee of
Kazakhstan’s Medical University «KSPH» (Almaty, Kazakhstan) approved the study.
Results: The high number of Almaty city respondents in comparison of the Kyzylorda region unsatisfactory with the
level of the providing information on the effect of ICD (P <0.009), the impact of ICD on driving a car, traveling, playing
sports or other activities, what shock means and when they occur, and how daily life might change (P <0.046). Only
respondents from Almaty city assessed neutral or unsatisfactory (P <0.004) on informing how to care for a wound after
implantation and to manage pain, symptoms and medication when returning home (P <0.002).
Conclusion: There are needs to improve in providing information on effects of ICD technology in Almaty city higher
in comparison with Kyzylorda region.